| Expression pattern: |
UP |
| Associated gene: |
CCNE1 |
| Associated microRNA: |
miR-103a-3p |
| Biological function: |
Promotes NSCLC cell proliferation and cell cycle progression; high expression is associated with advanced TNM stage and lymph-node metastasis. |
| Molecular mechanism: |
hsa_circ_0062389 functions as a ceRNA/miRNA sponge for miR-103a-3p to mediate CCNE1 expression in NSCLC. |
| Biological pathway or process: |
proliferation (promotes); cell cycle (promotes); ceRNA regulation (promotes) |
| Detected method: |
Q
|
| Validation methods: |
RNase R Treatment; RT-qPCR; Clinical Sample Validation; Luciferase Reporter Assay; Transfection; CCK8; Colony Formation Assay; Cell Cycle Assay; Bioinformatics Analysis |
| Clinical significance: |
High hsa_circ_0062389 expression was associated with advanced TNM stage, lymph-node metastasis and poor prognosis in NSCLC patients. |
| Description: |
hsa_circ_0062389 is up-regulated in NSCLC tissues and cell lines and is associated with advanced TNM stage, lymph-node metastasis and poor prognosis. Functionally, it promotes NSCLC cell proliferation and cell cycle progression. Mechanistically, it acts as a sponge for miR-103a-3p to increase CCNE1 expression, forming the hsa_circ_0062389/miR-103a-3p/CCNE1 axis. |
| Confidence score: |
0.7129 |